The syndrome of renal ischemia-reperfusion;Le syndrome d'ischemie reperfusion renale

Nephrologie

Volumn 20, Issue 7, 1999, Pages 371-375

  Hourmant, M ^a  

^a HÔTEL DIEU   (France)

Author keywords

Adhesion molecules; Reactive oxygen species; Reperfusion injury

Indexed keywords

CELL ADHESION MOLECULE; CHEMOATTRACTANT; CHEMOKINE; CYTOKINE; OXYGEN RADICAL; FREE RADICAL;

ARTICLE; CELL HYPOXIA; CYTOKINE RELEASE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LEUKOCYTE ACTIVATION; REPERFUSION INJURY; HEMODYNAMICS; HUMAN; ISCHEMIA; KIDNEY; LEUKOCYTE; PHYSIOLOGY; REVIEW; SYNDROME; VASCULARIZATION;

CELL HYPOXIA; FREE RADICALS; HEMODYNAMIC PROCESSES; HUMANS; ISCHEMIA; KIDNEY; LEUKOCYTES; REPERFUSION INJURY; SYNDROME;

EID: 0033252079     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Land W, Messmer K. The impact of ischemia reperfusion injury on specific and non specific early and late chronic events in organ transplantation. Transpl Reviews 1996; 10: 236-53.
2. Edelstein CL, Ling H, Schreier RW. The nature of cell injury. Kidney Int 1997; 51: 1341-51.
3. Wang GL, Jiang BH, Rue EA, Semanza GL. Hypoxia-inducible factor-1 is a basic helix-loop-helix PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-14.
4. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth gene expression in endothelial cells. Circ Res 1995; 77: 638-43.
5. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen regulated control elements in the phosphoglycerate kinase-1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci USA 1994; 91: 6496-500.
6. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cisacting sequences. J Biol Chem 1995; 270: 29083-9.
7. Lee PJ, Jiang BH, Chin BY, Iyer NV, Adam J, Semanza GL, Choi AMK. HIF-1 mediates transcriptional activation of the Heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997; 272: 5375-81.
8. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesia L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxyde synthase promoter. J Exp Med 1995; 182: 1683-93.
9. Brezis M, Rosen S. Hypoxia of the renal medulla; its implications for disease. N Engl J Med 1995; 332: 647-55.
10. Graven KK, Farber KW. Endothelial hypoxic stress proteins. Kidney Int 1997; 51: 426-37.
11. Hellberg O, Kallskog O. Neutrophil mediated post-ischemic tubular leakage in the rat kidney. Kidney Int 1989; 36: 555-61.
12. Noiri E, Romanov V, Forest T, Gailit J, Dibona GF, Miller F, Son P, Oster ZH, Goligorsky SM. Pathophysiology of renal tubular obstruction: Therapeutic role of synthetic RGD peptides in acute renal failure. Kidney Int 1995; 48: 1375-85.
13. Goligorsky SM, Noiri E, Kessler H, Romanov V. Therapeutic potential of RGD peptides in acute renal failure. Kidney Int 1997; 51: 1487-92.
14. Muraoka KI, Shimizu K, Sun X, Zhang YK, Tani T, Hashimoto T, Yagi M, Miyazaki I. Yamamoto KI. Hypoxia but not reoxygenation induces IL6 gene expression through NFKB activation. Transplantation 1997; 63: 466-70.
15. Jassem W, Roake J. The molecular and cellular basis of reperfusion injury following organ transplantation. Transplant Reviews 1998: 12: 14-33.
16. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic tubular necrosis induce an extensive local cytokine response: Evidence for induction of IFNγ, TGFβ1, GM-CSF, IL2 and IL10. Transplantation 1995; 59: 565-72.
17. Gianello P, Saliez A, Bufkens X, Pettinger R, Misseleyn D, Hori S, Malfroy B. Euk-134, a synthetic SOD and catalase mimetic, protects rat kidney from ischemia reperfusion induced damage. Transplantation 1996; 62: 1664-6.
18. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylate inhibits 1KB phosphorylation, endothelial leukocytic adhesion molecule expression aid neutrophil transmigration. J Immunol 1996; 156: 3961-9.
19. Zager RA. Conrad DS. Desferrioxamine confers striking protection against cold storage injury to isolated mouse proximal tubular cells. Kidney Int 1996; 50: 2109-11.
20. Fukuzawa K, Ernre S, Senyuz O, Arcali K, Schwartz ME, Miller CM. N acetyl cysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 1995: 59: 6-9.
21. Land W, Schneeberger H, Schleibner S, Illner WD, Abendroth D, Rutili G, Arfors KE, Messmer K. The beneficial effect of human recombinant superoxyde dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994;57:211-7.
22. Brady HR. Leucocyte adhesion molecules and kidney diseases. Kidney Int 1994; 45: 1285-300.
23. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interaction with granulocytes: tethering and signaling molecules. Immunol Today 1992; 13: 93-9.
24. Kubes P, Ibbotson G, Russell J. Role of platelet activating factor in ischemia reperfusion induced leucocyte adherence. Am J Physiol 1990; 259: G300-10.
25. Schall TJ, Bacon KB. Chemokines in leucocyte trafficking and inflammation. Current Opin Immunol 1994; 6: 865-9.
26. Schlonndorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int 1997; 51: 610-21
27. Bianchi E, Bender JR, Blasi F, Pardi R. Through and beyond the wall: Late steps in leucocyte transendothelial migration. Immunol Today 1997; 18: 586-91.
28. Kelly KJ. Williams WW, Colvin RB. Bonventre JV. Antibody to ICAM-1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994; 91: 812-6.
29. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (Enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation. A report of the european anti-ICAM-1 renal transplant study group. Transplantation 1999; 67: 729-36.
30. Hourmant M, Bedrossian J, Durand D, Lebranchu Y, Renoult E, Caudrelier P, Buffet R, Soulillou JP. A randomized multicenter trial comparing LFA-1 monoclonal antibody with rabbit anti-thymocyte globulin as induction treatment in first kidney transplantation. Transplantation 1996; 62: 1565-70.
31. Grino JM. BN 52021 : A Platelet Activating Factor antagonist for preventing post-transplant renal failure. A double blind randomized study. Ann Int Med 1994; 121: 345-7.
32. Rabb H, O'Meara YM, Maderna P. Coleman P, Brady HR. Leukocyte, cell adhesion molecules and ischemic renal failure. Kidney Int 1997; 51: 1463-8.
33. McLean AG, Hughes D, Welsh KI. Gray DWR, Roake J, Fuggle SV, Morris PJ, Dallman MJ. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 1997; 63: 374-80.
34. Chandraker A, Takada M, Nadeau KC, Peach R, Tilney NL, Sayegh M. CD28-B7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int 1997; 52: 1678-84.
35. Ling H, Gengaro PE, Edelstein CL, Martin PY, Wangsiripaisan A, Nemenoff R, Schreier RW. Effects of hypoxia on proximal tubules isolated from nitric oxyde KO mice. Kidney Int 1998; 53: 1642-6.
36. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996; 97: 2377-83.
37. Ong ACM. Tubulointerstitial actions of endothelin in the kidney: Role in health and disease. Nephrol Dial Transplant 1996; 11: 251-7.
38. Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P. Reversal of post-ischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin Invest 1994; 93: 900-6.
39. Espinoza G, Farre L, Cernadas MR, Manzarbeitia F. Tan D, Digiuni E, Mosquera JR, Monton M, Millas I, Hernando L, Casada S, Caramelo C. Role of endothelin in the pathophysiology of renal ischemia reperfusion in normal rabbits. Kidney Int 1996; 50: 776-82.
40. Cecka JM, Cho YW, Terasaki PI. Analyses of the UNOS registry at 3 years. Early events affecting transplant success. Transplantation 1992; 53: 59-64.
41. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmoudcr RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-74.
42. Giral M, Hourmant M, Cantarovich D, Dantal J, Blancho G, Daguin P, Ancelet D, Soulillou JP. Delayed graft function of more than 6 days strongly decreases long term survival of transplanted kidneys. Kidney Int 1998; 54: 972-8.
43. Orphanides C, Fine LG, Norman JT. Hypoxia stimulates proximal tubular cell matrix production via a TGFβ1 independant mechanism. Kidney Int 1997; 52: 637-47.
44. Kourembanas S, Morita T, Liu Y, Christou H. Mechanisms by which oxygen regulates gene expression and cell-cell interactions in the vasculature. Kidney Int 1997; 51: 438-43.